Clinical Trial Update: A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating solifenacin succinate in combination with tamsulosin for residual overactive bladder symptoms in men has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Solifenacin succinate (solifenacin)
• Tamsulosin (tamsulosin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Urinary Incontinence | Phase 4 | Status: COMPLETED